Contasta I - Search Results

1

Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy.

Contasta I, Pellegrini P, Berghella AM, Del Beato T, Adorno D. Contasta I, et al. Cancer Biother Radiopharm. 2006 Oct;21(5):488-505. doi: 10.1089/cbr.2006.21.488. Cancer Biother Radiopharm. 2006. PMID: 17105421

2

Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer.

Berghella AM, Contasta I, Pellegrini P, Del Beato T, Adorno D. Berghella AM, et al. Among authors: contasta i. Cancer Biother Radiopharm. 2002 Feb;17(1):43-50. doi: 10.1089/10849780252824064. Cancer Biother Radiopharm. 2002. PMID: 11915173

3

Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions.

Contasta I, Berghella AM, Pellegrini P, Adorno D. Contasta I, et al. Cancer Biother Radiopharm. 2003 Aug;18(4):549-57. doi: 10.1089/108497803322287628. Cancer Biother Radiopharm. 2003. PMID: 14503949

4

The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer.

Pellegrini P, Berghella AM, Contasta I, Del Beato T, Adorno D. Pellegrini P, et al. Among authors: contasta i. Cancer Biother Radiopharm. 2006 Oct;21(5):443-67. doi: 10.1089/cbr.2006.21.443. Cancer Biother Radiopharm. 2006. PMID: 17105419

5

Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement?

Berghella AM, Contasta I, Pellegrini P, Del Beato T, Adorno D. Berghella AM, et al. Among authors: contasta i. Cancer Biother Radiopharm. 2006 Oct;21(5):468-87. doi: 10.1089/cbr.2006.21.468. Cancer Biother Radiopharm. 2006. PMID: 17105420

6

Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding.

Contasta I I, Pellegrini P, Berghella AM, Del Beato T, Canossi A, Maccarone D, Papola F, Adorno D, Casciani CU. Contasta I I, et al. Cancer Biother Radiopharm. 1997 Dec;12(6):385-93. doi: 10.1089/cbr.1997.12.385. Cancer Biother Radiopharm. 1997. PMID: 10851492

7

Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.

Contasta I, Pellegrini P, Berghella AM, Del Beato T, Canossi A, Di Rocco M, Adorno D, Casciani CU. Contasta I, et al. Cancer Biother Radiopharm. 1996 Dec;11(6):373-83. doi: 10.1089/cbr.1996.11.373. Cancer Biother Radiopharm. 1996. PMID: 10851498

8

The TH1 and TH2 cytokine network in healthy subjects: suggestions for experimental studies to create prognostic and diagnostic indices for biotherapeutic treatments.

Pellegrini P, Contasta I, Berghella AM, Del Beato T, Casciani CU, Adorno D. Pellegrini P, et al. Among authors: contasta i. Cancer Biother Radiopharm. 2000 Jun;15(3):267-78. doi: 10.1089/108497800414365. Cancer Biother Radiopharm. 2000. PMID: 10941534

9

Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules.

Contasta I, Pellegrini P, Berghella AM, Adorno D. Contasta I, et al. Cancer Biother Radiopharm. 2001 Feb;16(1):63-71. doi: 10.1089/108497801750096069. Cancer Biother Radiopharm. 2001. PMID: 11279799

10

Relationships between the activity of MMP1/TIMP1 enzymes and the TH1/TH2 cytokine network.

Contasta I, Berghella AM, Pellegrini P, Del Beato T, Casciani CA, Adorno D. Contasta I, et al. Cancer Biother Radiopharm. 1999 Dec;14(6):465-75. doi: 10.1089/cbr.1999.14.465. Cancer Biother Radiopharm. 1999. PMID: 10850333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters